rs1126535

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000074.3(CD40LG):​c.148T>C​(p.Leu50Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.196 in 1,207,132 control chromosomes in the GnomAD database, including 17,805 homozygotes. There are 78,582 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.19 ( 1547 hom., 6545 hem., cov: 22)
Exomes 𝑓: 0.20 ( 16258 hom. 72037 hem. )

Consequence

CD40LG
NM_000074.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.309
Variant links:
Genes affected
CD40LG (HGNC:11935): (CD40 ligand) The protein encoded by this gene is expressed on the surface of T cells. It regulates B cell function by engaging CD40 on the B cell surface. A defect in this gene results in an inability to undergo immunoglobulin class switch and is associated with hyper-IgM syndrome. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant X-136648396-T-C is Benign according to our data. Variant chrX-136648396-T-C is described in ClinVar as [Benign]. Clinvar id is 518406.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-136648396-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.309 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.36 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CD40LGNM_000074.3 linkc.148T>C p.Leu50Leu synonymous_variant Exon 1 of 5 ENST00000370629.7 NP_000065.1 P29965

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CD40LGENST00000370629.7 linkc.148T>C p.Leu50Leu synonymous_variant Exon 1 of 5 1 NM_000074.3 ENSP00000359663.2 P29965

Frequencies

GnomAD3 genomes
AF:
0.189
AC:
21030
AN:
111467
Hom.:
1543
Cov.:
22
AF XY:
0.193
AC XY:
6535
AN XY:
33913
show subpopulations
Gnomad AFR
AF:
0.153
Gnomad AMI
AF:
0.0539
Gnomad AMR
AF:
0.369
Gnomad ASJ
AF:
0.150
Gnomad EAS
AF:
0.0861
Gnomad SAS
AF:
0.332
Gnomad FIN
AF:
0.188
Gnomad MID
AF:
0.162
Gnomad NFE
AF:
0.177
Gnomad OTH
AF:
0.208
GnomAD3 exomes
AF:
0.239
AC:
43636
AN:
182396
Hom.:
4641
AF XY:
0.233
AC XY:
15625
AN XY:
67200
show subpopulations
Gnomad AFR exome
AF:
0.153
Gnomad AMR exome
AF:
0.507
Gnomad ASJ exome
AF:
0.149
Gnomad EAS exome
AF:
0.0874
Gnomad SAS exome
AF:
0.338
Gnomad FIN exome
AF:
0.205
Gnomad NFE exome
AF:
0.181
Gnomad OTH exome
AF:
0.224
GnomAD4 exome
AF:
0.197
AC:
216125
AN:
1095610
Hom.:
16258
Cov.:
30
AF XY:
0.199
AC XY:
72037
AN XY:
361642
show subpopulations
Gnomad4 AFR exome
AF:
0.148
Gnomad4 AMR exome
AF:
0.498
Gnomad4 ASJ exome
AF:
0.150
Gnomad4 EAS exome
AF:
0.103
Gnomad4 SAS exome
AF:
0.328
Gnomad4 FIN exome
AF:
0.202
Gnomad4 NFE exome
AF:
0.182
Gnomad4 OTH exome
AF:
0.198
GnomAD4 genome
AF:
0.189
AC:
21047
AN:
111522
Hom.:
1547
Cov.:
22
AF XY:
0.193
AC XY:
6545
AN XY:
33978
show subpopulations
Gnomad4 AFR
AF:
0.153
Gnomad4 AMR
AF:
0.370
Gnomad4 ASJ
AF:
0.150
Gnomad4 EAS
AF:
0.0864
Gnomad4 SAS
AF:
0.332
Gnomad4 FIN
AF:
0.188
Gnomad4 NFE
AF:
0.177
Gnomad4 OTH
AF:
0.213
Alfa
AF:
0.185
Hom.:
12265
Bravo
AF:
0.204
EpiCase
AF:
0.176
EpiControl
AF:
0.171

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 61% of patients studied by a panel of primary immunodeficiencies. Number of patients: 58. Only high quality variants are reported. -

Hyper-IgM syndrome type 1 Benign:2
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Mar 03, 2015
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
4.5
DANN
Benign
0.78

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1126535; hg19: chrX-135730555; COSMIC: COSV65698528; API